Experimental Adenovirus COVID Injections Continuing to Kill Younger, Middle-Aged People

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

***

The AstraZeneca and Johnson & Johnson experimental adenovirus COVID shots seem to be killing younger, middle-aged people at a higher rate than the mRNA shots from Pfizer and Moderna.

Here are the stories of some of the victims who have died following the injections and devastated their families.

*

Francine Boyer: 54-year-old Canadian woman develops blood clots, dead 14 days after experimental AstraZeneca shot

by The COVID Blog

A 54-year-old woman is dead, and Canadian mainstream media are reaching for the stars with their propaganda.

Mrs. Francine Boyer and her husband, Alain Serres, both received experimental AstraZeneca shots on April 9, according to a family press release. Mr. Serres suffered no apparent adverse effects. But Mrs. Boyer suffered from extreme fatigue and debilitating headaches. She checked into a local hospital, but doctors could not figure out what was wrong. She was transferred to Montreal Neurological Institute-Hospital.

Doctors diagnosed her with cerebral thrombosis, aka blood clots in her brain. She died on April 23. Canadian mainstream media and politicians commenced a Fauci-Biden-like public relations campaign defending experimental viral vector shots after Mrs. Boyer died. Quebec Premier François Legault told state-run CBC/Radio Canada, “we knew there was a once chance in 100,000 this could happen.” He said the death of Mrs. Boyer is “sad,” but the benefits of experimental AstraZeneca shots outweigh the risks.

National Director of Public Health Dr. Horacio Arruda offered even more big pharma propaganda. He said Mrs. Boyer’s death is “very rare” and “sometimes, unfortunately, there are complications.” Health Canada, a Canadian hybrid equivalent to the CDC and FDA, also said in a statement that the benefits of AstraZeneca shots outweigh the risks.

Mrs. Boyer is survived by her husband, who posted on social media the other day “I love you and I will love you forever!” She is also survived by two grown children, two grandchildren, and her siblings.

Read the full story at The COVID Blog.

Genene Norris: 48-year-old Australian woman develops blood clots, dead six days after AstraZeneca shot

by The COVID Blog

A 48-year-old woman is dead after yet another “rare coincidence” involving COVID-19 shots.

Ms. Genene Norris received the experimental AstraZeneca viral vector shot on April 8, according to the Daily Mail. She almost immediately fell ill. Doctors diagnosed her with “rare” blood clots and placed her on dialysis in the ICU four days after the shot. That indicates kidney failure. She died on April 14.

The Australia Therapeutic Goods Administration (TGA) is at least being semi-honest about the situation. A spokesperson said the blood clots were “likely linked to the vaccine.” But the agency doesn’t have much choice after a string of deaths related to the experimental shots.

The Northern Daily Leader reported that a “fit and healthy” 55-year-old died in Tamworth, New South Wales on April 21. The newspaper did not name him. But we’re told his name is Darren Lee Missen. He had “massive blood clots” in his lungs after a COVID-19 shot. There were at least four other cases of blood clots in Australia after AstraZeneca shots in the last several weeks. Despite the TGA’s kind-of-honest statement, deputy secretary John Skerritt told the Australian Broadcasting Corporation that the benefits of AstraZeneca shots outweigh the risks. He did not articulate any tangible benefits in his statement.

Ms. Norris worked for Sanitarium Health Food Company. It is solely owned by the Seventh-day Adventist Church, which encourages adherents to “responsibly participate in protective and preventive immunization programs.” The company said in a statement that it is “saddened by the loss of a much loved employee.”

Read the full story at The COVID Blog.

Jack Last: 27-year-old British engineer dead 21 days after experimental AstraZeneca viral vector shot

by The COVID Blog

Mr. Jack Last had a pilot license, traveled everywhere from New Zealand to Antarctica, and was a scuba diver. His life was tragically cut short because of yet another coincidence.

Mr. Last received the experimental AstraZeneca viral vector shot on March 30, according to The Sun U.K. He suffered from excruciating headaches thereafter, which forced him to check into A&E at West Suffolk Hospital on April 9. His condition worsened, prompting doctors to transfer him to Addenbrooke’s Hospital in Cambridge. But they could do nothing to save the “fit and healthy” young man, as described by his family. He died on April 20.

A kangaroo “inquest” has been launched into Mr. Last’s death. He obviously died from blood clots in his brain, as nearly every experimental viral vector victim does. The Medical Healthcare Products and Regulatory Agency (MHRA) is the U.K. equivalent to the U.S. Food and Drug Administration. The agency admitted last week that the risk factor for these “rare” blood clots doubled last week.

Meanwhile the European Medicines Agency says the alleged benefits of experimental viral vectors still outweigh the risks of “rare” blood clots. Many European countries temporarily paused use of AstraZeneca shots due to blood clots, just like the United States did for the experimental Johnson & Johnson viral vector shots.

Mr. Last told family that he was surprised to be offered the shot because of his young age. He had also just recently purchased a home.

Read the full story at The COVID Blog.

Ionia Co. woman’s death after getting J&J vaccine reported to the CDC

by FOX 17 Western Michigan

An Ionia family is mourning the death of a wife and mother after they say she died due to complications after receiving the Johnson & Johnson coronavirus vaccine.

The family of 35-year-old Anne VanGeest released a statement following her death on April 19.

“It is with profound sadness that we share the news of Anne’s passing as the result of complications after receiving the Johnson & Johnson COVID-19 vaccine. Anne (Annie), who was 35, was a loving mother, wife, sister and daughter. An active member in the animal rescue community, Annie will be remembered as a fierce advocate, a master-multi-tasker and a caring friend by her colleagues, fellow volunteers and family. We ask for privacy for her family as they mourn Annie’s passing and celebrate her life.”

In an email to the VanGeest family, the U.S. Centers for Disease Control and Prevention (CDC) confirmed her death had been reported through the Vaccine Adverse Event Reporting System (VAERS) by a healthcare provider. VAERS is a vaccine safety system managed by the CDC and the FDA.

VanGeest died on April 19. According to her family, VanGeest received the Johnson & Johnson COVID-19 vaccine 11 days before her death.

VanGeest’s death certificate lists her cause of death as “acute subarachnoid hemorrhage non-traumatic.”

Read the full story at FOX 17 Western Michigan.

*

Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from Health Impact News


Articles by: Brian Shilhavy

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]